Lupin (LUPIN) — Financial Results

Lupin Limited reported audited consolidated revenue of ₹19,551.8 crores for Q4 FY2025, up 32% YoY, driven by strong domestic performance and new product launches. Net profit rose 69.9% to ₹7,948.6 crores YoY, reflecting improved margins and cost efficiencies. The company highlighted strategic progress in reducing US market reliance and expanding UK textile exports under a new FTA.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 16 May 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 16 May 2025

TATAPOWER Tata Power Company Limited Financial Results SHRIRAMFIN Shriram Finance Limited Corporate Action APOLLOHOSP Apollo Hospitals Enterprise Limited Corporate Action BRITANNIA Britannia Industries Limited Financial Results CIPLA Cipla Limited Financial Results DELHIVERY Delhivery Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.